Navigation Links
CU-Boulder worm study sheds light on human aging, inherited diseases
Date:10/1/2007

Microscopic worms used for scientific research are living longer despite cellular defects, a discovery that is shedding light on how the human body ages and how doctors could one day limit or reverse genetic mutations that cause inherited diseases, according to a new University of Colorado at Boulder study.

In the first formal study of its kind, researchers manipulated the metabolic state of genetically engineered lab worms called C. elegans and discovered a window of high-efficiency cellular processing that enabled the worms to slow their rate of aging. The findings could one day contribute to the creation of gene therapies to reverse or lessen the effects of mitochondrial diseases, the largest family of human genetic diseases, said lead study author Shane Rea of CU-Boulder's Institute for Behavioral Genetics.

Diseases labeled as mitochondrial are those that affect the mitochondria, the membrane-enclosed power sources present in all cells, Rea said. Researchers believe their insights might find application in treating diseases linked to mitochondrial dysfunction such as Huntington's, Parkinson's and Alzheimer's.

"We appear to have found a window where life is able to preserve itself even better than when operating in the absence of any cellular defects," said Rea. "It's a metabolic state where cells are probably getting close to the best they can be for long life and good health."

Pioneering CU-Boulder worm researcher and Professor Thomas E. Johnson and the University of Rome's Natascia Ventura co-authored the study. Grants from the National Institutes of Health and other agencies funded the research. The findings will appear in the Oct. 2 edition of the Public Library of Science journal PLoS Biology.

Rea, who will continue his research at the University of Texas Health Science Center in San Antonio later this year, said the study validates the worm model for research into the causes of human aging and disea
'/>"/>

Contact: Shane Rea
srea@colorado.edu
303-492-2505
University of Colorado at Boulder
Source:Eurekalert

0

GOOD

Page: 1 2 3

Related biology news :

1. Morning grogginess more debilitating than sleep deprivation, according to CU-Boulder study
2. Bioartificial kidney under study at MCG
3. Novel Asthma Study Shows Multiple Genetic Input Required; Single-gene Solution Shot Down
4. W.M. Keck Foundation funds study of friendly microbes
5. Yellowstone microbes fueled by hydrogen, according to U. of Colorado study
6. Emory Study Tests Bone Marrow Stem Cells to Improve Circulation in Legs
7. UCLA Study Shows One-Third of Drug Ads in Medical Journals Do Not Contain References Supporting Medical Claims
8. Study Demonstrates Gene Expression Microarrays are Comparable and Reproducible
9. Study Links Ebola Outbreaks To Animal Carcasses
10. Genome-wide mouse study yields link to human leukemia
11. Breakthrough Microarray-based Technology for the Study of Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/20/2008)...from heart attacks. But to do that they have to pr...arlier this year, a team led by William Maisel at ...al radio transmitter could be used to modify wirel...t, 22 March, p 23). Doctors normally use these si...but a malicious hacker could reprogram the pacemak...
(Date:8/20/2008)... (CAMH) is proud to announce a landmark investment...ation (CFI) into research that will propel the und... of mental illness and addiction to the next level...cale Institutional Endeavours component of CFI,s R...our scientific strengths, and transform lives with...
(Date:8/20/2008)...ve found a way to convert ethanol and other biofue...yst makes hydrogen from ethanol with 90 percent yi...ive ingredients. , Umit Ozkan, professor of chem...iversity, said that the new catalyst is much less ...orld, because it does not contain precious metals,...
(Date:8/19/2008)...oring bran flakes; it can also preserve important ...Institute of Standards and Technology (NIST) have ... for evaluating the sugars pharmaceutical companie...om temperature. The group presented their findings...Meeting and Exposition. , Protein-based drugs su...
Breaking Biology News(10 mins):How to stop a new type of heart attack 2Large-scale investment catapults CAMH's mental illness and addiction research forward 2A better way to make hydrogen from biofuels 2A better way to make hydrogen from biofuels 3Candy-coating keeps proteins sweet 2Vaccine for Ebola virus 2664 1Vaccine for Ebola virus 2664 2Increased Heart Risk Seen for Retired NFL Players 15469 1Increased Heart Risk Seen for Retired NFL Players 15469 2Major international collaboration offers new clues to genetics of type 2 diabetes 2662 1Major international collaboration offers new clues to genetics of type 2 diabetes 2662 2Major international collaboration offers new clues to genetics of type 2 diabetes 2662 3Comparison of anticoagulants for angioplasty show similar outcomes 15466 1Comparison of anticoagulants for angioplasty show similar outcomes 15466 2
...shows that statins, which are typically used as an...ation of the hepatitis C virus (HCV). They could r...feron. These findings are published in the July 20...e American Association for the Study of Liver Dise...Inc., Hepatology is available online via Wiley Int...
...uard turned traitor, a protein whose regular job i...me cases, join forces with another protein to do t... new research at the University of Minnesota. The ...damage, for example, from ultraviolet light, and a... can become dysfunctional or cancerous. The protei...
...hers report that thousands of genes behave differe...thing never detected to this degree. Published in...eds light on why the same disease often strikes ma...ay respond differently to the same drug. , "We pr...s vary in their relationship to different diseases...
...artment of Energy (DOE) today released an ambitiou...losic ethanol as an alternative to gasoline. The ...s in biotechnology that have made cost-effective p...lant fiber, an attainable goal. The report outlin...hnologies to transform cellulosic ethanol--a renew...
Other Biology News:Statins stop hepatitis C virus from replicating 2University of Minnesota researchers take new look at cellular suicide 2UCLA study finds same genes act differently in males and females 2UCLA study finds same genes act differently in males and females 3DOE publishes research roadmap for developing cleaner fuels 2
(Date:8/21/2008)... NEW YORK, MUNICH, Germany and AMSTERDAM, Neth...thcare and SpePharm Holding, B.V., the,pan-Europea...d that they,have entered into a euro 10 million re...fund SpePharm,s acquisition of Dantrium(R) for Eur...le Pharmaceuticals. At the same,time, TVM Capital,...
(Date:8/20/2008)... VIENNA, Va., Aug. 20 /PRNewswire-USNewswire/ ...0 ranking of the fastest-growing private companies...T) services provider,MicroTech, ranks No. 285 on ... 2008 Inc. 500 list measures revenue growth from 2...U.S.-based, privately held, independent -,no subsi...
(Date:8/20/2008)... INDIANAPOLIS, Ind., Aug. 20 /PRNewswire-First... announced that it has completed the acquisition,o...n Diego-based,biotechnology company focused on dru...y. The completion of the deal followed today,s Spe...SGX stockholders voted in,favor of the merger agre...
(Date:8/20/2008)... Growth Fueled by Popularity with Seniors and ... Marketing, CAMBRIDGE, Mass., Aug. 20 /PRNewswi...hole Health (SWH), a voluntary health care plan fo...ng private company in the,United States., Part of...rowing,companies, SWH had revenue growth of 31,000...
Breaking Biology Technology:TVM Capital, Signet Healthcare Partners and Paul Capital Healthcare Enter into euro 26 Million Financing of SpePharm 2TVM Capital, Signet Healthcare Partners and Paul Capital Healthcare Enter into euro 26 Million Financing of SpePharm 3TVM Capital, Signet Healthcare Partners and Paul Capital Healthcare Enter into euro 26 Million Financing of SpePharm 4TVM Capital, Signet Healthcare Partners and Paul Capital Healthcare Enter into euro 26 Million Financing of SpePharm 5MicroTech Ranks No. 285 on Inc. Magazine's 2008 List of the 500 Fastest Growing Private Companies in America 2Lilly Announces Completion of SGX Acquisition 2Inc. Magazine Names Senior Whole Health the Number One Fastest-Growing Private Company in US 2Inc. Magazine Names Senior Whole Health the Number One Fastest-Growing Private Company in US 3
... about the size and growth of the medical device i...week,s column will focus on the leading players in...mment on some trends from this table, here are a c... here is the major part of the diagnostics busines...h includes clinical and molecular diagnostics. Thi...
La Crosse, Wis. - Firstlogic, Inc., announced today an expansion of its OEM partnership with Informatica Corp. of Redwood City, Calif., involving Firstlogic,s Data Quality Link for Informatica. , ,
...tics, Inc., has become is the first seed lab in th...ccredited Seed Lab (ASL) program, administered by...), the company reported Tuesday. , , BioDiagnostic...n testing services. , ,The ASL Program is a volun...aboratories. Seed testing laboratories, which meet...
...stems, Inc. has received FDA approval to market i...nced Tuesday. It will start marketing the system d... intended to monitor physiological parameters of p...ign allows a variety of optional configurations th... around the world. , ,Criticare designs, manufactu...
Other Biology Technology:Midwest plays key role in developing new medical device companies 2Midwest plays key role in developing new medical device companies 3
Rabbit polyclonal to Shigella Immunogen: Mixture of S. boydii, S. flexneri & S. dysenteriae.
...n cullin genes (CUL-1, -2, -3, -4a, -4b, and -5), ...-3 is proposed to be a part of E3 protein-ubiqutin...and targets it for ubiquitination, which leads to ...vator of cdk2, which leads the cell to S phase. Cu...
...ludes interface cable to S2000; can be mounted wit... The LS-450 Blue LED Pulsed Light Source is an L...t at 470 nm -- the blue region -- for fluorescence... Ocean Optics spectrometers configured for fluore...
Clear amber to slightly cloudy liquid. Yellow, oily, bacterial suspension. Contains 10 vials per set, each containing 10 ml of Freund's complete adjuvant homogenized in the following proportions by
Biology Products: